Clinical Partners Welcome

TAE Life Sciences is dedicated to thorough clinical investigation and validation of BNCT. We are seeking institutional partners to conduct the necessary research and clinical trials using our proprietary BNCT platform to establish efficacy and regulatory approval.

We are confident that the combination of BNCT's considerable therapeutic potential, our innovations in accelerator-based neutron beam delivery, and the number of patients who can benefit from the research we do together, makes TAE Life Sciences an unparalleled opportunity.


Investment Partners Welcome

TAE Life Sciences is interested in meeting potential investors whose charter aligns with our mission to make BNCT a widely available cancer treatment. By leveraging a promising therapeutic modality and a proprietary neutron beam delivery system, we believe we represent a compelling funding opportunity for those focused on life sciences.